The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Press Commentary

28 Oct 2022 07:00

RNS Number : 4301E
Bidstack Group PLC
28 October 2022
 

28 October 2022

Bidstack Group Plc

("Bidstack" or the "Company" or the "Group")

Update re Press Commentary

Further to the Company's strategy update to the market on 26 October 2022, the Board notes recent press commentary regarding a private communication by the Company with certain investors concerning an email received from Azerion, which the Directors have been advised did not require disclosure under either the AIM Rules or MAR. In order to ensure that all shareholders have parity of information the Company wishes to give this update.

After the announcement on 5 October 2022 of the Group's Fundraise, Bidstack received an email from Azerion requesting certain information and reserving its rights under the Azerion agreement.

Given the nature of the Group's strong ongoing commercial relationship with Azerion and the extensive work taking place on the ground to ensure the success of the partnership by both Azerion and Bidstack, the Directors were surprised to receive this email.  At a commercial level, the Group's arrangements with Azerion continue to be operated on a 'business as usual' basis by both parties, with October already the highest grossing month to date and with November and December anticipated to grow further month on month. Bidstack has responded with detailed information demonstrating the Group's compliance with all areas identified. Bidstack has taken appropriate external legal advice and has concluded that Azerion has no present entitlement to end its agreement with the Group.

As referred to in the Company's announcement on 26 October 2022, following early evidence of its success in selling directly into North America and Japan, Bidstack intends to undertake a comprehensive business review, specifically reassessing and renegotiating, where appropriate, both existing and new reseller engagements in all geographies in order to maximise the benefits of its contacts with developers, publishers, ad-tech vendors and media companies.

Bidstack notes that Azerion is primarily a European-based group, with its sales-reach strongest in these territories. As announced on 20 September and 13 and 26 October, Bidstack has now invested in an experienced sales team with a proven track record in North America, which has a robust pipeline for FY23.

Bidstack's newly appointed Group Chief Revenue Officer is in active discussions on a number of significant global revenue opportunities, including additional resellers, licensors and media agreements, with anticipated contracts in FY23.

The Company would like to stress that, contrary to the press commentary, there is no litigation with Azerion, and the contract with Azerion continues to operate as expected.

The Directors also confirm that there are no discussions with Azerion regarding any offer for the Company.

The Board believes that the Company is trading in line with market expectations for the years ended 31 December 2022 and 2023.

-ENDS-

Contacts

Bidstack Group Plc

James Draper, CEO

 

via Buchanan

SPARK Advisory Partners Limited (Nomad)

Mark Brady / Neil Baldwin / James Keeshan

 

+44 (0) 203 368 3550

Stifel Nicolaus Europe Limited (Broker)

Fred Walsh / Tom Marsh

 

+44 (0) 20 7710 7600

Buchanan Communications Limited

Chris Lane / Stephanie Whitmore / Kim van Beeck

bidstack@buchanan.uk.com

 

+44 (0) 20 7466 5000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFIFEIILLTFIF
Date   Source Headline
19th Feb 20187:00 amRNSUpdate
27th Nov 20171:29 pmRNSTR-1: notification of major holdings
23rd Nov 20177:50 amRNSHolding(s) in Company
21st Nov 20178:13 amRNSHolding(s) in Company
17th Nov 20174:39 pmRNSTR-1: notification of major holdings
17th Nov 20174:38 pmRNSTR-1: notification of major holdings
15th Nov 201710:33 amRNSDirector/PDMR Shareholding - Issue of Warrants
15th Nov 20178:05 amRNSChange of Registered Office, Co. Secretary & TVR
15th Nov 20178:01 amRNSBoard changes effective
15th Nov 20177:00 amRNSUpdate on Suspension, CVA, Placing
14th Nov 20177:00 amRNSDirector/PDMR Shareholding
13th Nov 201711:06 amRNSResult of General Meeting
27th Oct 20177:00 amRNSConsolidation of share capital & GM Notice
26th Oct 20177:00 amRNSSuspension update & proposed share consolidation
25th Oct 20174:42 pmRNSTotal Number of CVA Capitalisation Shares
24th Oct 20171:08 pmRNSResult of CVA and General Meeting
5th Oct 20177:00 amRNSProposed CVA, Placing and Board Changes update
3rd Oct 20175:01 pmRNSProposed CVA, Placing and proposed Board Changes
28th Sep 20177:00 amRNSInterim results for six months ended 30 June 2017
11th Sep 20175:39 pmRNSUpdate re suspension
31st Aug 20179:40 amRNSUpdate re suspension: Administrators appointed
23rd Aug 20172:56 pmRNSUpdate re suspension
20th Jul 20179:19 amRNSLoan Note Conversion, Issue of Warrants & Equity
18th Jul 20177:30 amRNSStatement re. Suspension
18th Jul 20177:30 amRNSSuspension - Kin Group plc
7th Jul 20173:15 pmRNSTR-1: Notification of major interest in shares
3rd Jul 20177:00 amRNSConversion of loan notes, issue of warrants &TVR
20th Jun 20177:00 amRNSNon Regulatory - new contract - NHS Trust
14th Jun 20177:00 amRNSGrant of Options
13th Jun 20177:00 amRNSConvertible Loan Notes update
30th May 20177:00 amRNSConversion of Loan Notes, Issue of Warrants & TVR
15th May 20177:00 amRNSConvertible Loan Note Facility
5th May 201712:16 pmRNSResult of AGM, Change of Name and TVRs
11th Apr 20173:06 pmRNSPosting of Annual Report and Notice of AGM
11th Apr 20177:00 amRNSNon Regulatory - Customer renewal
5th Apr 20171:27 pmRNSPublication of Annual Report & Accounts
4th Apr 20177:00 amRNSProposed Change of Name
3rd Apr 20177:00 amRNSFinal Results for the year ended 31 December 2016
22nd Feb 20177:00 amRNSNon Regulatory - New client contract win
16th Feb 20177:00 amRNSNon Regulatory - Results of Case Study
13th Feb 20177:00 amRNSChange of Registered Office
25th Jan 20177:00 amRNSCompletion of Placing
19th Jan 20171:30 pmRNSRestoration - Fitbug Holdings plc
19th Jan 201712:57 pmRNSTrading Update
18th Jan 20173:23 pmRNSSuspension - Fitbug Holdings Plc
18th Jan 20177:00 amRNSNew customer win covering 14,000 employees
16th Jan 20177:00 amRNSChange of Adviser
13th Dec 20167:00 amRNSCorporate Wellness Partnership
8th Nov 20167:00 amRNSDirectorate Change
21st Sep 201611:15 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.